Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Rheumatology
Polymyalgia rheumatica
Questions discussed in this category
What lab markers are helpful for monitoring polymyalgia rheumatica patients on tocilizumab?
Since tocilizumab is known to normalize ESR/CRP, are there any markers/blood tests that may be helpful to check for PMR patients with question of exac...
1 Answer available
Do you monitor RS3PE patients for GCA with the same vigilance that you do in PMR patients?
1 Answer available
Is there a role for tocilizumab in treatment of polymyalgia rheumatica in patients who do not have features of giant cell arteritis or rheumatoid arthritis?
1 Answer available
11887
8416
7868
Papers discussed in this category
,
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
Rheumatol Ther, 2021 Mar 21
Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade.
Related Topics in Rheumatology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Genitourinary Cancers
Melanoma/Skin Cancer